Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 1;5:PO.20.00445. doi: 10.1200/PO.20.00445

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG 2. — Genomic landscape of advanced breast cancer in premenopausal women. Oncoprint depicting the results of patient's ctDNA NGS data. MONALEESA-7 cfDNA at screening: Genes with frequency > 5% or genes of interest are included. BOR, best overall response; cfDNA, circulating free DNA; CR, complete response; ctDNA, circulating tumor DNA; NCRNPD, neither complete response nor progressive disease; NGS, next-generation sequencing; PBO, placebo; PD, progressive disease; PFS, progression-free survival; PR, partial response; RIB, ribociclib; SD, stable disease; SV, structural variations; UNK, unknown.